Annual Congress Stockholm 2002

Saturday, 14.09.2002
Sunday, 15.09.2002
Monday, 16.09.2002
Tuesday, 17.09.2002
Wednesday, 18.09.2002

Citations should be made in the following way: Authors. Title. Eur Respir J 2002; 20: Suppl. 38, abstract number.


Material from 2002:
  • 3388  Abstracts
  • 6 Slide presentations
  • 5 Handouts
Material from 2002:  Show

Steroid and other anti-inflammatory agents

Thematic Poster Session
Chairs: M. Peters (Concord, Australia), I. M. Adcock (London, United Kingdom)
Cost-minimisation analysis of two different inhaled steroids in persistent bronchial asthma
C. Terzano, P. Berto, G. Cremonesi, C. Pulli (Rome, Verona, Parma, Italy)
Congress or journal article abstract
Congress or journal article abstract
The effect of two month's treatment with fluticasone (F) at a dose of 500 mg per day versus fluticasone at a dose of 250 mg per day plus salmeterol (S) 100 mg per day in patients with moderate asthma
J. Wrońska, R. Chazan, A. Safianowska, J. Mazurek, H. Grubek-Jaworska (Warsaw, Poland)
Congress or journal article abstract
Congress or journal article abstract
Treatment of asthma with lipid extract of New Zealand green-lipped mussel: a double blind, randomized placebo-controlled clinical trial
A. V. Emelyanov, G. B. Fedoseev, O. I. Krasnoschekova, A. Abulimiti, T. E. Trendeleva, P. J. Barnes (St-Petersburg, Russia; London, United Kingdom)
Congress or journal article abstract
Congress or journal article abstract
Leukotriene C4 synthase polymorphism does not associate with clinical response to leukotriene receptor antagonists in persistent asthma
G. P. Currie, J. J. Lima, J. E. Sylvester, D. K. C. Lee, W. J. R. Cockburn, B. J. Lipworth (Dundee, United Kingdom; Jacksonville, United States Of America)
Congress or journal article abstract
Congress or journal article abstract
Effect of inhaled corticosteroids over glucose metabolism
M. M. Zdraveska, D. T. Dimitrievska, A. S. Gjorcev, D. L. Todevski (Skopje, Macedonia)
Congress or journal article abstract
Congress or journal article abstract
Roflumilast, a new, orally active, selective phosphodiesterase 4 inhibitor, is safe and well tolerated in patients with chronic obstructive pulmonary disease
S. Leichtl, J. Syed, D. Bredenbröker, F. Rathgeb, W. Wurst (Konstanz, Germany)
Congress or journal article abstract
Congress or journal article abstract
Roflumilast, a new, orally active, selective phosphodiesterase 4 inhibitor, is effective in the treatment of asthma
S. Leichtl, C. Schmid-Wirlitsch, D. Bredenbröker, F. Rathgeb, W. Wurst (Konstanz, Germany)
Congress or journal article abstract
Congress or journal article abstract
Effect of guaifenesin on cough reflex sensitivity
P. V. Dicpinigaitis, Y. E. Gayle (Bronx, United States Of America)
Congress or journal article abstract
Congress or journal article abstract
Efficacy of diltiazem administration on the respiratory adverse effects of enalapril
S. Franova, G. Nosalova (Martin, Slovakia)
Congress or journal article abstract
Congress or journal article abstract
Comparison of roflumilast, a new, orally active, selective phosphodiesterase 4 inhibitor, with beclomethasone dipropionate in asthma control
A. Albrecht, S. Leichtl, D. Bredenbröker, T. Bethke, W. Wurst (Konstanz, Germany)
Congress or journal article abstract
Congress or journal article abstract
Effect of cysteinyl leukotriene receptor antagonist on airway wall remodeling
H. Masuda, M. Toda, G. Cheng, K. Honda, F. Eda, Y. Aoki, T. Fukuda (Mibu, Japan)
Congress or journal article abstract
Congress or journal article abstract
Morning and evening administration of inhaled ciclesonide is equally effective in treatment of asthma
D. S. Postma, N. Schlösser, C. Sevette, Y. Martinat, J. Aumann, H. Kafé (Groningen, Heidelberglaan, The Netherlands; Perpignan, Lyon, St-Quentin, France; Hasselt, Belgium)
Congress or journal article abstract
Congress or journal article abstract
Bioequivalence of two ciclesonide dosing regimens (4 puffs of 200μg vs. 8 puffs of 100μg using an MDI)
A. Drollmann, T. D. Bethke, R. Nave, K. Zech, B. Hauns, V. W. Steinijans, W. Wurst (Konstanz, Germany)
Congress or journal article abstract
Congress or journal article abstract
Adherence with two types of inhaled corticosteroids as a primary controller regimen in adult asthma patients
K. Fujita, Y. Nagasaka, M. Fujita, N. Nakano, A. Miyatake (Hikone, Sakai, Kyoto, Osaka, Japan)
Congress or journal article abstract
Congress or journal article abstract
Efficacy of high-dose inhaled fluticasone propionate in Indian patients having moderate asthma
S. K. Agarwal (Varanasi, India)
Congress or journal article abstract
Congress or journal article abstract
Inhaled corticosteroids in the treatment of acute asthma
F. R. Jerez, M. Brufal, J. Bellido, G. Margarit, M. Torrejon, J. Belda, P. Casan, J. Sanchis (Barcelona, Spain)
Congress or journal article abstract
Congress or journal article abstract
Asthma and once-daily administration of inhaled corticosteroids: potential for improved compliance and reduced health costs
R. B. Coambs, J. L. Jarry, A. H. Rattray, B. S. Ferguson, J. Witt, F. G. De Maio, R. Abrahamsohn, A. Santhiapillai (Toronto, Canada)
Congress or journal article abstract
Congress or journal article abstract
The patterns of inadequate drug administration in children with asthma: a multi-center retrospective study
N. A. Smirnov, I. V. Smolenov, J. J. Zima, N. G. Mashukova, V. I. Petrov (Volgograd, Irkutsk, Russia)
Congress or journal article abstract
Congress or journal article abstract
The influence of inhaled corticosteroids on the cytokine indexes of pregnant women with asthma
V. Koupaev, L. Limareva (Samara, Russia)
Congress or journal article abstract
Congress or journal article abstract
Early intervention with budesonide in mild persistent asthma - the START study. On behalf of the START investigators group

Congress or journal article abstract
Congress or journal article abstract